News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Valeant Pharmaceuticals International (VRX) Sees Bausch & Lomb Acquisition as China Entry


5/30/2013 9:29:31 AM

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

by Richard Daverman, PhD

May 29, 2013 -- Valeant Pharma, Canada’s largest drugmaker, announced yesterday it would pay $8.7 billion to acquire Bausch & Lomb. With the transaction, Valeant bought a substantial portfolio of eye care products, but it also acquired, for the first time, a sales foothold in China. Valeant said it would leverage B&L’s China organization to bring its own products to the PRC. More details....

Stock Symbol: (NYSE: VRX)



Help employers find you! Check out all the jobs and post your resume.

Read at ChinaBio Today

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES